The Effect of Virtual Reality Glasses on Vital Signs and State Anxiety in Patients Undergoing Coronary Angiography

NCT ID: NCT07032935

Last Updated: 2025-09-03

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 84 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-07-15
• Study Completion Date: 2025-08-15

Brief Summary

Virtual reality (VR) glasses are an effective non-pharmacological method for reducing anxiety, supported by a high level of evidence and associated with no known side effects. Techniques involving relaxation and distraction, such as VR, function by suppressing the sympathetic branch of the autonomic nervous system and activating the parasympathetic branch, thereby eliciting a relaxation response.

VR glasses divert the patient's attention away from pain and anxiety. By reducing the sense of unfamiliarity in clinical environments, VR helps patients adapt more easily, leading to enhanced relaxation. This state of relaxation not only alleviates anxiety but also induces favorable physiological responses. These include reductions in blood pressure (BP), heart rate (HR), and respiratory rate (RR), along with an increase in peripheral oxygen saturation (SpO₂). Additionally, the psychological benefits of VR contribute to the reduction of anxiety, stress, fear, and worry.

VR is considered a cost-effective, safe, and non-pharmacological intervention. Several studies support its efficacy. For example, in a study comparing the effects of video games played through VR headsets and iPads on preoperative anxiety in adult patients undergoing sternotomy, anxiety was measured using the Depression Anxiety Stress Scale (DASS), and lower anxiety levels were observed in the VR group. Another study demonstrated that watching nature scenes through VR glasses for five minutes prior to maxillofacial surgery significantly reduced anxiety. Furthermore, research comparing progressive muscle relaxation exercises and VR during arthroscopic knee surgery-measured using the State Anxiety Inventory-indicated that both non-pharmacological interventions were effective in reducing anxiety.

However, despite this growing body of evidence, no study to date has examined the effects of VR applications on anxiety in patients undergoing coronary angiography or pacemaker implantation. This study aims to fill that gap by investigating the comparative effectiveness of virtual reality applications in reducing anxiety in patients undergoing coronary angiography.

Conditions

Coronary Angiography (CAG)

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: SINGLE

Study Groups

Control Group

No intervention will be made to the patient during the Coronary Angiography application.

Group Type: NO_INTERVENTION

No interventions assigned to this group

virtual reality glasses Group

Group Type: EXPERIMENTAL

Virtual Reality Glasses will be used DURING CORONARY ANGIOGRAPHY APPLICATION

Intervention Type: BEHAVIORAL

Virtual Reality Glasses will be used DURING CORONARY ANGIOGRAPHY APPLICATION

Interventions

Virtual Reality Glasses will be used DURING CORONARY ANGIOGRAPHY APPLICATION

Virtual Reality Glasses will be used DURING CORONARY ANGIOGRAPHY APPLICATION

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Are over 18 years of age,
• Do not have any psychiatric illness,
• Do not have any vision, hearing or perception problems,
• Are at least a primary school graduate,
• Do not have any disorder/disease affecting decision-making ability (dementia, psychological disorder, etc.)
• Volunteer to participate in the study,
• Are open to communication and cooperation.

Exclusion Criteria

• Patients who receive sedation, patients who cannot communicate, patients with visual or hearing impairments, and individuals who do not agree to participate in the research will be included.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 70 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Kutahya Health Sciences University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Kutahya Health Sciences University

Merkez, Kütahya, Turkey (Türkiye)

Countries

Turkey (Türkiye)

Other Identifiers

KutahyaHSU20240106

Identifier Type: -

Identifier Source: org_study_id